Daiwa Securities Group’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.26M | Buy |
46,642
+559
| +1% | +$39.1K | 0.01% | 521 |
|
2025
Q1 | $3.39M | Buy |
46,083
+786
| +2% | +$57.8K | 0.01% | 474 |
|
2024
Q4 | $2.97M | Sell |
45,297
-10,193
| -18% | -$668K | 0.01% | 501 |
|
2024
Q3 | $4.32M | Buy |
55,490
+20,398
| +58% | +$1.59M | 0.02% | 407 |
|
2024
Q2 | $2.74M | Buy |
35,092
+1,981
| +6% | +$155K | 0.01% | 479 |
|
2024
Q1 | $2.24M | Sell |
33,111
-148,145
| -82% | -$10M | 0.01% | 518 |
|
2023
Q4 | $12.2M | Buy |
181,256
+1,018
| +0.6% | +$68.6K | 0.08% | 145 |
|
2023
Q3 | $12.2M | Sell |
180,238
-35,000
| -16% | -$2.37M | 0.09% | 138 |
|
2023
Q2 | $15.4M | Sell |
215,238
-1,368
| -0.6% | -$97.9K | 0.1% | 110 |
|
2023
Q1 | $15M | Buy |
216,606
+28,403
| +15% | +$1.97M | 0.1% | 110 |
|
2022
Q4 | $12.8M | Buy |
188,203
+179
| +0.1% | +$12.1K | 0.1% | 127 |
|
2022
Q3 | $10.3M | Buy |
188,024
+8,859
| +5% | +$486K | 0.09% | 137 |
|
2022
Q2 | $11.8M | Sell |
179,165
-27,615
| -13% | -$1.82M | 0.09% | 117 |
|
2022
Q1 | $13.7M | Sell |
206,780
-111,121
| -35% | -$7.37M | 0.09% | 120 |
|
2021
Q4 | $18.5M | Buy |
317,901
+69,395
| +28% | +$4.04M | 0.11% | 101 |
|
2021
Q3 | $14.9M | Buy |
248,506
+45,552
| +22% | +$2.74M | 0.1% | 109 |
|
2021
Q2 | $12.2M | Sell |
202,954
-1,318
| -0.6% | -$78.9K | 0.08% | 126 |
|
2021
Q1 | $10.2M | Sell |
204,272
-133,890
| -40% | -$6.66M | 0.08% | 130 |
|
2020
Q4 | $16.9M | Buy |
338,162
+67,632
| +25% | +$3.38M | 0.13% | 81 |
|
2020
Q3 | $14.8M | Buy |
270,530
+55,183
| +26% | +$3.02M | 0.13% | 74 |
|
2020
Q2 | $9.62M | Hold |
215,347
| – | – | 0.2% | 61 |
|
2020
Q1 | $9.62M | Buy |
215,347
+12,541
| +6% | +$560K | 0.1% | 99 |
|
2019
Q4 | $10.1M | Buy |
202,806
+88,961
| +78% | +$4.44M | 0.08% | 109 |
|
2019
Q3 | $5.07M | Buy |
+113,845
| New | +$5.07M | 0.04% | 191 |
|